ImmunoGen - Delisted Stock
ImmunoGen is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day ImmunoGen was actively traded.
ImmunoGen Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ImmunoGen market risk premium is the additional return an investor will receive from holding ImmunoGen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ImmunoGen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ImmunoGen's alpha and beta are two of the key measurements used to evaluate ImmunoGen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.99 | |||
| Semi Deviation | 0.7035 | |||
| Standard Deviation | 10.35 | |||
| Variance | 107.2 |
View ImmunoGen Related Equities
| Risk & Return | Correlation |
ImmunoGen Corporate Directors
ImmunoGen corporate directors refer to members of an ImmunoGen board of directors. The board of directors generally takes responsibility for the ImmunoGen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ImmunoGen's board members must vote for the resolution. The ImmunoGen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Howard Pien | Independent Director | Profile | |
| Kristine Peterson | Independent Director | Profile | |
| Nicole Onetto | Independent Director | Profile | |
| Mark Goldberg | Independent Director | Profile |
Still Interested in ImmunoGen?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the ImmunoGen information on this page should be used as a complementary analysis to other ImmunoGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in ImmunoGen Stock
If you are still planning to invest in ImmunoGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoGen's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |